In this study, we show in in vitro and in vivo models that treatment of CML cells with Curcumin caused a miR-21-mediated modulation of PTEN/AKT pathway leading to the inhibition of leukemic cell growth. This evidence concerns the gene AKT1 and chronic myelogenous leukemia, BCR-ABL1 positive.